The Pierre Fabre group, Platinum Sponsor at the 25th World Congress of Dermatology in Singapore
3 July 2023
From July 3rd to 8th, 2023, The Pierre Fabre group, 2nd largest dermo-cosmetics laboratory in the world and 2nd largest private pharmaceutical group in France, will be actively participating in the 25th World Congress of Dermatology in Singapore. As a platinum sponsor of the event, the Group demonstrates its commitment to advancing research and innovation in the specialized fields of dermatology and oncology. With the participation of eight brands from the group, such as Pierre Fabre Innovative Oncology, Pierre Fabre Medical Dermatology, Eau Thermal Avène, Ducray, A-derma, René Furterer, Klorane, and Pierre Fabre Eczema Foundation, this massive presence showcases the company's willingness to share its expertise, the holistic approach of health care thanks to it’s the complementarity of its portfolio, ethic and dermocosmetic and foster expertise and foster international collaboration.
On this occasion, we invite you to join our teams to discover our innovations and our holistic approach in the management of dermatological diseases.
As platinum sponsor of the congress, we will be glad to welcome you with our medical teams on our booth to find out more about
The Group takes pride in having around 150 participants at this global event. Among them, 100 distinguished guests will join the company's staff members to discuss the latest communications in dermatology and oncodermatology. The Group has reserved an impressive 300 square meters of exhibition space for its booth, providing dermatologists with a unique opportunity to explore the products (from ethic to dermocosmetic), the digital medical services (Dermaweb and Pierre FABRE for MED) and innovations (including Interactome) developed by the Group's brands.
Pierre FABRE group is presenting for the first time 25 posters out of which 3 will be feature posters. As part of the World Congress of Dermatology, the Group is hosting two high-level symposia to share knowledge and present its latest research.
Symposium on July 4th:
Title: "Patients as Partners in Dermatology: How to Better Meet Patient Needs through a Holistic Approach. Artificial Intelligence and R&D Innovation as Key Success."
Chairman: Professor STOCKFLETH Eggert (Germany)
Symposium on July 6th:
Title: "Prevention, Early Detection, and Management of Skin Cancer: New Weapons for Tomorrow's Battles."
Chairman: Professor HAUSCHLD Axel (Germany)
The World Congress of Dermatology in Singapore offers the Group an ideal platform for establishing partnerships, exchanging ideas, and sharing knowledge with global experts. Representatives from the group will have the opportunity to participate in interactive sessions, meet renowned clinicians, researchers, and specialists in the field. The Group aims to strengthen its ties with the international dermatological community and collaborate on future scientific advancements.
At our company’s core is a dual expertise that enables us to use science and conduct research at the same level for medicines as for dermo-cosmetic, and this World Congress proves that we have our place among the physicians in this field.
CEO of the Pierre Fabre Group
Eric Ducournau, CEO and Francesco Hofmann, Head of R&D Medical care give an overview of the PierreFabre Group's ambitions at the 25th World Congress of Dermatology.